Saxena Parag's Form 4 filing
Reviva Pharmaceuticals Holdings, Inc. (RVPH) · filed Sep 12, 2022
- Accession no.
- 0001104659-22-099268
- Filed
- Sep 12, 2022, 4:34 PM ET
- Trade date
- Sep 8, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 0 non-derivative transactions and 4 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Saxena ParagCIK 0001015823 | 10% Owner |
| Vedanta Partners, LLCCIK 0001502216 | 10% Owner |
| Vedanta Associates, L.P.CIK 0001502222 | 10% Owner |
| Beta Operators Fund, L.P.CIK 0001614642 | 10% Owner |
| Vedanta Associates-R, LPCIK 0001865703 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2022 | Common Stock | PPurchaseAcquired | +869,565 | $2.53 | +$2,199,912.49 | 869,565 | Indirect | |
| Sep 8, 2022 | Common Stock | PPurchaseAcquired | +513,834 | $2.53 | +$1,299,948.64 | 513,834 | Indirect | |
| Sep 8, 2022 | Common Stock | PPurchaseAcquired | +869,565 | $0.0001 | +$86.96 | 869,565 | Indirect | |
| Sep 8, 2022 | Common Stock | PPurchaseAcquired | +513,834 | $0.0001 | +$51.38 | 513,834 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.